MediMix Oncology
  • Home
  • Congresses
    • 2026
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Webinars
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
SIOG 2025

Interim analysis of the Robo-G study

3 December 2025

Presented by Prof Dr Lore Decoster (University Hospital Brussels, Belgium)

Prof Dr Lore Decoster discusses the Interim analysis of the Robo-G study which investigates the feasibility and functional outcomes of robotic surgery in older patients with newly diagnosed colorectal cancer.

The Robo-G study is a prospective observational study including patients aged 70 years or older with colorectal cancer who are eligible for robotic surgical treatment. Participants are followed for a period of one year and undergo repeated comprehensive geriatric assessments. At baseline, prior to surgery, patients are evaluated with respect to functional status, mood, nutritional status, and quality of life. Functional status is assessed using activities of daily living (ADL), instrumental activities of daily living (IADL), grip strength, and the Timed Up and Go test.

Follow-up assessments are conducted at 3 months, 6 months, and 12 months after surgery to evaluate postoperative evolution and recovery. The poster presented focuses specifically on functional outcomes over time. Results indicate that the majority of patients maintain stable functional status following robotic surgery. Stability is observed across basic and instrumental daily functioning, as well as objective physical performance measures such as grip strength and mobility.

Although a subset of patients demonstrates a transient decline in function at 3 or 6 months postoperatively, most exhibit functional recovery by one year after surgery. Overall, these findings suggest that robotic surgery is a feasible and well-tolerated treatment option for older patients with colorectal cancer. Ongoing follow-up aims to further elucidate long-term functional trajectories in this population.

References:

Van EetveldeE, et al. SIOG 2025; SIOG2025-P-128

Back to SIOG 2025

Tags:

poster

Share Article

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • ESMO GI 2025
      • ASCO 2025
      • EADO 2025
      • ELCC 2025
      • ENETS 2025
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Webinars
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.